JAM
AVXL icon

Jupiter Asset Management’s Anavex Life Sciences AVXL Stock Holding History

Jupiter Asset Management’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-804,642
Closed -$4.1M – 398
2024
Q1 		$4.1M Buy
804,642
+700,812
+675% +$3.94M 0.04% 264
2023
Q4 		$967K Buy
+103,830
New +$715K 0.01% 386

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jupiter Asset Management's AVXL Position: Q2 2024 in Review

Jupiter Asset Management sold out of Anavex Life Sciences (AVXL) in Q2 2024, closing a stake of 804,642 shares — an estimated $4.1M sold.

Jupiter Asset Management first reported a position in AVXL in Q4 2023 and held it in 2 quarters. The position peaked at $4.1M in Q1 2024. 141 funds tracked by Wall St. Rank hold AVXL as of Q2 2024.

  • Jupiter Asset Management reported no remaining Anavex Life Sciences position as of Q2 2024 after selling out during the quarter.
  • Jupiter Asset Management sold 804,642 Anavex Life Sciences shares in Q2 2024, an estimated $4.1M.
  • Jupiter Asset Management first reported a position in Anavex Life Sciences in Q4 2023 and held it in 2 quarters.
  • Jupiter Asset Management's Anavex Life Sciences position peaked at $4.1M in Q1 2024.
  • 141 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2024.

Based on Jupiter Asset Management's 13F filing for Q2 2024, filed 8 Aug 2024.